Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Varenicline Neuropsychiatric Symptoms in Smoking Cessation
NCT00749944Phase 4Completed
- Sponsor
- Pfizer
- Start
- Sep 2008
- Primary completion
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in nicotine dependence comparing Varenicline with Placebo (2 arms). Primary endpoints: Profile of Mood States: Total Mood Disturbance at 12 weeks, Profile of Mood States Subscales at 12 weeks and 5 more. Started Sep 2008; status: completed.
02
Drugs
varenicline
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT00749944.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00749944.